Cell/Gene Tx channel feed – Endpoints News

Cell/Gene Tx channel feed

Vertex says about 20 patients have started sickle cell therapy, cuts two rare disease programs

9 months ago

With $144M Series B, Outpace Bio beats funding goal for solid tumor cell therapies

9 months ago

Updated: Jim Wilson to step down from gene therapy post at UPenn, will form two new companies

9 months ago

Umoja to dose first patient with in vivo CAR-T by end of this year

9 months ago

Exclusive: Myeloid Therapeutics moves second in vivo cell therapy into trials, targeting liver cancer

9 months ago

Pfizer cuts 210 North Carolina workers after it officially discontinues failed Duchenne gene therapy

10 months ago

Artiva's IPO raises $167M to fund company's autoimmune and cancer cell therapies

10 months ago

4DMT builds out case for wet AMD gene therapy with new Phase 2 data

10 months ago

Adverum prepares pivotal study for wet AMD gene therapy, touts Phase 2 data

10 months ago

Caribou to slash preclinical allogeneic CAR-NK work, lay off 12% of staff

10 months ago

After last year's ImmunoGen pact, Vertex finds another conditioning agent partner in Orum

10 months ago

Updated: Lexeo Therapeutics' gene therapy shows potential for Friedreich's ataxia cardiomyopathy with early data

10 months ago

Artiva aims for $116M in second attempt at IPO to boost NK cell therapy pipeline

10 months ago

Roche's gene therapy biotech Spark is laying off employees, ending some early-stage programs

10 months ago

UniQure trumpets mid-stage data for Huntington's disease gene therapy

10 months ago

Infections are major cause of non-relapse deaths after CAR-T cell therapy, study shows

10 months ago

Exclusive: Gene insertion startup launches with new integrase technology from University of Hawaii

10 months ago

Beacon raises $170M to take on J&J in ocular gene therapy

10 months ago

J&J and Legend say Carvykti improved survival in earlier-line multiple myeloma

10 months ago

Cartesian clears an autoimmune CAR-T trial, starts another Phase 2 and raises $130M

10 months ago

FDA rejects Rocket Pharma’s ultra-rare immune disease gene therapy over manufacturing

11 months ago

Lyell reports patient death, early responses in solid tumor CAR-T trial

11 months ago

Can CRISPR be given twice? Small study from Intellia suggests it can

11 months ago

Can mRNA be harnessed for gene insertion? Moderna's former chief medical officer has $82M to find out

11 months ago

First page Previous page 4 5 678 9 10 Next page Last page